TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 73 filers reported holding TANGO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $348,925 | +237.6% | 30,988 | -0.5% | 0.00% | – |
| Q2 2023 | $103,368 | +27.7% | 31,135 | +51.9% | 0.00% | – |
| Q1 2023 | $80,943 | -32.2% | 20,492 | +24.5% | 0.00% | – |
| Q4 2022 | $119,342 | +37.2% | 16,461 | -14.4% | 0.00% | – |
| Q2 2022 | $87,000 | +443.8% | 19,225 | +837.8% | 0.00% | – |
| Q1 2022 | $16,000 | -42.9% | 2,050 | -20.7% | 0.00% | – |
| Q4 2021 | $28,000 | – | 2,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
| TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
| Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
| Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
| Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
| Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
| Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
| EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |